XNAS · Healthcare · Biotechnology
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Q1 2026 | -0.14 | -0.12 | +14.29% | $0 | ✅ Beat | +9.73% | +10.42% | +0.39% |
| 2026-02-26 | Q4 2025 | -0.14 | -0.11 | +21.43% | $0 | ✅ Beat | +0.00% | +0.83% | +43.80% |
| 2025-10-28 |
| Q3 2025 |
| -0.15 |
| -0.11 |
| +26.67% |
| $0 |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-31 | Q2 2025 | -0.14 | -0.12 | +14.29% | $0 | ✅ Beat | +7.88% | -2.00% | -10.53% |
| 2025-02-27 | Q4 2024 | -0.16 | -0.14 | +12.50% | $0 | ✅ Beat | +11.11% | -2.56% | -26.41% |
| 2024-10-29 | Q3 2024 | -0.16 | -0.13 | +18.75% | $0 | ✅ Beat | -4.33% | -4.69% | -19.13% |
| 2024-07-30 | Q2 2024 | -0.16 | -0.14 | +12.50% | $0 | ✅ Beat | +1.50% | -14.23% | -3.37% |
| 2024-04-30 | Q1 2024 | -0.16 | -0.15 | +6.25% | $0 | ✅ Beat | +9.45% | +8.66% | +3.94% |
Showing last 8 quarters.